1-3 of 3
Patricia Koenig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Analysis of a Multicenter Pilot Phase 2 Study of Ruxolitinib and Danazol in Patients with Myelofibrosis

Krisstina L. Gowin, DO, Heidi E. Kosiorek, MS, Amylou Constance Dueck, PhD, John Mascarenhas, Ronald Hoffman, MD, Craig B. Reeder, MD, John Camoriano, MD, Veena Fauble, MD, Raoul Tibes, MD, Katherine Gano, MS, Vineta Ghurye, Patricia Koenig, Ruben A. Mesa
Journal: Blood
Blood (2015) 126 (23): 1618.
https://doi.org/10.1182/blood.V126.23.1618.1618
Published: 2015
Journal Articles

Interim Analysis of a Phase II Pilot Trial of Ruxolitinib Combined with Danazol for Patients with Primary Myelofibrosis (MF), Post Essential Thrombocythemia-Myelofibrosis (Post ET), and Post Polycythemia Vera Myelofibrosis (PV MF) Suffering from Anemia

Krisstina L. Gowin, DO, Amylou C. Dueck, PhD, John O Mascarenhas, MD MS, Ronald Hoffman, MD, Craig B. Reeder, MD, John Camoriano, MD, Katherine Gano, MS, Vineta Ghurye, Sravan Nagi Reddy, Patricia Koenig, Veena Fauble, MD, Raoul Tibes, MD, Ruben Mesa, MD
Journal: Blood
Blood (2014) 124 (21): 3206.
https://doi.org/10.1182/blood.V124.21.3206.3206
Published: 2014
Journal Articles

A Phase II Study of Temsirolimus (CCI-779) in Combination with Rituximab in Patients with Relapsed or Refractory Mantle Cell Lymphoma.

Stephen M Ansell, Hui Tang, BS, MA, PhD, Paul Kurtin, Patricia Koenig, David J Inwards, Keith Shah, Thomas E Witzig, MD
Journal: Blood
Blood (2009) 114 (22): 1665.
https://doi.org/10.1182/blood.V114.22.1665.1665
Published: 2009